Clinical Trials for Malignant Neoplasm of Breast

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

NCT ID: NCT06878248

This clinical trial is studying a new treatment combination, CLBR001 and ABBV-461, for patients with locally advanced or metastatic breast cancer. This means it’s looking at how well these two ther...

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

NCT ID: NCT06251544

This clinical trial, called TRAIL-R2, is exploring a new treatment for patients with metastatic breast cancer that has a specific protein called HER2. The researchers are testing a special type of ...

Swedish Ibrance Registries Insights (SIRI)

NCT ID: NCT04654208

The Swedish Ibrance Registries Insights (SIRI) trial is studying how patients with breast cancer are treated with a medication called palbociclib in Sweden. The main goal of this study is to unders...

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

NCT ID: NCT03463954

This clinical trial is studying a new treatment called Novilase® Laser Therapy for women with small malignant (cancerous) breast tumors that are 15 mm or less in size. The goal is to see how well t...

Low-field MRI for Breast Cancer Screening

NCT ID: NCT05486520

Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery

NCT ID: NCT04669873

This clinical trial is investigating two different types of radiation therapy for women with early-stage breast cancer who have had surgery to remove the tumor while preserving the breast. The goal...